[187 (13.7%) to 32 (4.7%) at 12 months; P<0.05]
[<55 mg/dL; −0.38/24-h day; P<0.0001]
[<55 mg/dL; −0.12/24-h day; P=0.0017]
[18.5% to 7.7%; P<0.05]
[5.8% to 2.9%; P<0.0001]
The FreeStyle Libre 3 app is only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Use of the FreeStyle Libre 3 app requires registration with LibreView.
The FreeStyle Libre 2 system and FreeStyle Libre 3 system are indicated for patients ages 4 and older.
* Data from this study was collected with the outside US version of the FreeStyle Libre 14 day system. FreeStyle Libre 3 has the same features as FreeStyle Libre 14 day system with real-time glucose alarms. Therefore the study data is applicable to both products.
† Data from this study was collected with the outside US version of the FreeStyle Libre 14 day system. FreeStyle Libre 2 has the same features as FreeStyle Libre 14 day system with optional real-time glucose alarms. Therefore the study data is applicable to both products.
‡ A meta-analysis of RCTs and single arm studies (in addition to real world observational studies) on the impact of flash continuous glucose monitoring on glycemic control as measured by HbA1c.
§ Represents percentage of people experiencing a diabetes-related hospital admission.
|| Represents inpatient events or emergency outpatient events for hypoglycemia, hyperglycemia, diabetic ketoacidosis, or hyperosmolarity.
¶ Represents percentage of patients reporting work absenteeism.
References: 1. Yaron, M. Diabetes Care (2019): https://doi.org/10.2337/dc18-0166 2. Evans M, et al. Diabetes Therapy (2022): https://doi.org/10.1007/s13300-022-01253-9 3. Campbell, F. Pediatr Diabetes (2018): https://doi.org/10.1111/pedi.12735 4. Fokkert, M. BMJ Open Diabetes Res & Care (2019): https://doi.org/10.1136/bmjdrc-2019-000809 5. Bergenstal, R. J Endocr Soc (2021): https://doi.org/10.1210/jendso/bvab013 6. Bolinder, J. The Lancet (2016): https://doi.org/10.1016/s0140-6736(16)31535-5 7. Haak, T. Diabetes Ther (2017): https://doi.org/10.1007/s13300-016-0223-6 8. Charleer S, et al. Diabetes Care (2020): https://doi.org/10.2337/dc19-1610 9. Tyndall, V. Diabetologia (2019): https://doi.org/10.1007/s00125-019-4894-1 10. Kroger, J. Diabetes Ther (2020): https://doi.org/10.1007/s13300-019-00741-9 11. Carlson AL, et al. BMJ Open Diabetes Res Care (2022): https://doi.org/10.1136/bmjdrc-2021-002590 12. Miller E, et al. AJMC (2021): https://doi.org/10.37765/ajmc.2021.88780 13. Wright, E. Diabetes Spectr (2021): https://doi.org/10.2337/ds20-0069 14. Kerr M, et al. Poster presented at the ATTD Conference, Madrid, Spain, February 19-22, 2020. https://doi.org/10.1089/dia.2020.2525.abstracts 15. Deshmukh, H. Diabetes Care (2020): https://doi.org/10.2337/dc20-0738
ADC-17131 v6.0 06/22
Payer.freestylelibre.us/en is a product-specific website intended only for residents of the United States.
If you are a resident of another country, please contact your local Abbott affiliate to obtain the appropriate product information for your country of residence.
ADC-21099 v3.0 07/21